USANA Health Sciences Inc. said its normalized net income for the fiscal first quarter ended April 1 was 84 cents per share, compared with the S&P Capital IQ consensus estimate of 92 cents per share.
EPS rose year over year from 82 cents.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was $20.9 million, a gain from $20.6 million in the prior-year period.
The normalized profit margin fell to 8.2% from 8.6% in the year-earlier period.
Total revenue increased 6.2% on an annual basis to $255.3 million from $240.4 million, and total operating expenses rose 7.5% on an annual basis to $222.4 million from $206.9 million.
Reported net income declined year over year to $21.5 million, or 86 cents per share, from $22.4 million, or 89 cents per share.